Vergoeding 2015-2019 voor ATC-subgroep J01 : Antibacteriele middelen voor systemisch gebruik
- Raming voor de totale Zvw-populatie
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| J01A Tetracyclines | 3.778.400 | 3.407.400 | 3.158.100 | 2.766.300 | 2.600.900 |
| J01B Amfenicolen | . | . | . | . | 10 |
| J01C Betalactam-antibiotica penicillines | 8.794.000 | 8.314.800 | 7.978.700 | 8.714.800 | 10.286.200 |
| J01D Overige betalactam-antibiotica | 4.043.100 | 4.415.200 | 4.399.200 | 4.697.100 | 5.355.300 |
| J01E Sulfonamiden en trimethoprim | 1.026.500 | 1.018.100 | 1.008.200 | 1.070.900 | 1.323.500 |
| J01F Macroliden lincosamiden en streptograminen | 4.483.200 | 3.769.000 | 3.969.600 | 4.013.700 | 4.745.300 |
| J01G Aminoglycosiden | 5.906.300 | 5.480.100 | 4.955.400 | 4.485.900 | 4.373.100 |
| J01M Chinolonen | 1.790.100 | 1.592.100 | 1.747.300 | 2.146.800 | 2.305.100 |
| J01X Overige antibacteriele middelen | 11.558.400 | 11.012.200 | 10.260.600 | 9.616.800 | 10.216.900 |
| Totaal | 41.380.000 | 39.008.900 | 37.477.100 | 37.512.300 | 41.206.310 |